Drugmakers Play The Patent Game To Lock In Prices, Block Competitors

Re:Drugmakers Play The Patent Game To Lock In Prices, Block ... by snarfy on Saturday September 29, 2018 @07:50AM (#18099865)

I'm not sure where that $1.5B figure came from but the caveat I've always heard that came along with it is that drug companies pay less than 10% of the actual research costs. The rest is made up from government grants and university research. They mention the total costs to make themselves sound like victims.

[ Parent | on HN ]

Re:Drugmakers Play The Patent Game To Lock In Prices, Block ... by aaavl2821 on Saturday September 29, 2018 @12:13PM (#18101121)

That is simply not true. The $1.5B is cost spent to get a single drug approved and includes cost of failure, i.e. Spend on drugs that end up not getting approved. The data that supports this comes from a sampling of pharma company r&d spend

The NIH funds about $30B in research each year, NSF about $7B. The top 15 pharma companies spend ~$70B on r&d a year. VCs invest $10-15B / year as of the last few years. Globally all pharma companies spend over $200B on r&d

[ Parent | on HN ]